Biotricity raises $500K in Series B Preferred placement; up to $1.5M additional

BIOTRICITY INC.

Issued 55 Series B Preferred shares at $9,090.91 each for gross proceeds of $500,000 on June 21, 2024.
Potential additional closings up to $1,500,000 through December 31, 2024 at investor's sole discretion.
Series B Preferred carries 8% cumulative dividend (15% on triggering event), convertible at $3.50/share.
Alternate conversion price at 80% (or 70% if suspended/delisted) of lowest VWAP during measuring period.
Company must seek stockholder approval by August 15, 2024; registration rights penalty of 100,000 common shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.